Ticker League

EBITDA for Henry Schein (HSIC)

Latest filings through · Reported

Metric

TTM

$1.00B

YoY change

+6.9%

5Y CAGR

+6.7%

Peak year (2017)

$1.07B

EBITDA history chart for Henry Schein (HSIC) from 1994 to 2025

Latest: $1.01B

EBITDA growth chart for Henry Schein (HSIC) from 1994 to 2025

Latest: +6.9%

EBITDA history table for Henry Schein (HSIC) from 1994 to 2025

  • 2025$1.01B+6.9%
  • 2024$941.00M+7.3%
  • 2023$877.00M-10.2%
  • 2022$977.00M-8.5%
  • 2021$1.07B+46.9%
  • 2020$726.81M-20.7%
  • 2019$916.04M+21.1%
  • 2018$756.48M-29.3%
  • 2017$1.07B+11.7%
  • 2016$957.51M+5.7%
  • 2015$905.89M+2.3%
  • 2014$885.61M+8.0%
  • 2013$820.27M+7.9%
  • 2012$760.41M+6.3%
  • 2011$715.58M+12.3%
  • 2010$637.21M+14.2%
  • 2009$557.78M+9.8%
  • 2008$508.18M+5.6%
  • 2007$481.36M+24.2%
  • 2006$387.49M+16.6%
  • 2005$332.46M+24.3%
  • 2004$267.55M-0.6%
  • 2003$269.14M+19.5%
  • 2002$225.28M+22.8%
  • 2001$183.39M+13.6%
  • 2000$161.38M+9.4%
  • 1999$147.46M+26.9%
  • 1998$116.18M+48.4%
  • 1997$78.30M+40.6%
  • 1996$55.70M+28.6%
  • 1995$43.30M-859.6%
  • 1994−$5.70M—

EBITDA values are taken from Henry Schein's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About EBITDA at Henry Schein (HSIC)

According to Henry Schein's latest reported financial statements, the company's current EBITDA (TTM) is $1.00B. EBITDA stands for earnings before interest, taxes, depreciation, and amortization. It is a common proxy for operating cash generation that strips out non-cash charges (depreciation and amortization) and capital structure effects (interest, taxes). Useful for comparing companies with different leverage and asset bases — see operating income and net income for fully GAAP figures.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

As of the 2025 fiscal year, Henry Schein (HSIC) reported EBITDA of $1.01B – grew 6.9% year-over-year.

Over 2020–2025 (5 years), Henry Schein EBITDA expanded at a +6.7% compound annual rate, sustaining 2 straight years of year-over-year growth.

Henry Schein EBITDA declined from $1.07B in 2017 to $1.01B in 2025, a 5.9% drawdown.

The record annual EBITDA stands at $1.07B, reached in 2017; the historical low of −$5.70M was recorded in 1994.

Henry Schein EBITDA by Year

Henry Schein EBITDA 2025: $1.01B

Henry Schein EBITDA in 2025 was $1.01B, grew 6.9% from 2024.

Henry Schein EBITDA 2024: $941.00M

2024's EBITDA for Henry Schein came in at $941.00M, grew 7.3% from 2023.

Henry Schein EBITDA 2023: $877.00M

Henry Schein posted EBITDA of $877.00M in 2023, declined 10.2% below 2022.

Henry Schein EBITDA 2022: $977.00M

In 2022, Henry Schein reported EBITDA of $977.00M, declined 8.5% below 2021.

Henry Schein EBITDA 2021: $1.07B

Henry Schein EBITDA in 2021 was $1.07B.

See more financial history for Henry Schein (HSIC).

Sector peers by EBITDA

Healthcare peers of Henry Schein (HSIC), ranked by their latest EBITDA

Frequently asked questions

Henry Schein (HSIC) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation